Global Next Generation Sequencing Technology Market Research Report 2024

Publication ID:

PB502252036

Publication Date:

February 28, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Next Generation Sequencing (NGS) is a high-throughput method for rapid sequencing of base pairs of DNA or RNA samples. Next generation sequencing systems can be divided by three parts, instruments, consumables and related services. At the same time, NGS also supports a wide range of applications, including gene expression profiling, chromosome counting, epigenetic change detection, and molecular analysis, which can drive discovery research and realize the bright future of personalized medicine.

The global Next Generation Sequencing Technology market was valued at US$ 4486 million in 2023 and is anticipated to reach US$ 12360 million by 2030, witnessing a CAGR of 15.4% during the forecast period 2024-2030.

The Next Generation Sequencing (NGS) Technology market is driven by the increasing demand for personalized medicine and advancements in genomic research. NGS technology enables rapid and high-throughput DNA and RNA sequencing, offering insights into genetic variations and molecular profiles for various applications in healthcare and life sciences. The rise in genetic diseases and cancer cases contributes to market growth as researchers and clinicians seek comprehensive genetic information for diagnosis, treatment, and drug development. Moreover, technological innovations in sequencing platforms and data analysis align with improved accuracy, speed, and cost-effectiveness of sequencing processes. However, the market also faces challenges, including managing and interpreting large volumes of genomic data and addressing ethical and privacy concerns related to genetic information. Additionally, ensuring standardization and quality control in NGS workflows and navigating regulatory requirements can pose obstacles for stakeholders. To succeed, companies must focus on data analytics solutions, collaborations in multi-omics research, and addressing the challenges to meet the increasing demand for NGS technology that drives advancements in personalized medicine and genomics research.

This report aims to provide a comprehensive presentation of the global market for Next Generation Sequencing Technology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Next Generation Sequencing Technology.

Report Scope

The Next Generation Sequencing Technology market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Next Generation Sequencing Technology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Next Generation Sequencing Technology companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

Eurofins Scientific

Natera

BGI

Illumina

Roche

LabCorp

Berry Genomics

Brooks Life Sciences

Macrogen

Personalis

Novogene

Genotypic Technology

Dna Link

Segment by Type

Targeted Sequencing

Whole Exome Sequencing

Whole Genome Sequencing

Segment by Application

Hospitals and Clinics

Biopharma Companies

Academic & Research Organizations

Others

By Region

North America

United States

Canada

Europe

Germany

France

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Next Generation Sequencing Technology companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Next Generation Sequencing Technology Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Targeted Sequencing

1.2.3 Whole Exome Sequencing

1.2.4 Whole Genome Sequencing

1.3 Market by Application

1.3.1 Global Next Generation Sequencing Technology Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospitals and Clinics

1.3.3 Biopharma Companies

1.3.4 Academic & Research Organizations

1.3.5 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Next Generation Sequencing Technology Market Perspective (2019-2030)

2.2 Next Generation Sequencing Technology Growth Trends by Region

2.2.1 Global Next Generation Sequencing Technology Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Next Generation Sequencing Technology Historic Market Size by Region (2019-2024)

2.2.3 Next Generation Sequencing Technology Forecasted Market Size by Region (2025-2030)

2.3 Next Generation Sequencing Technology Market Dynamics

2.3.1 Next Generation Sequencing Technology Industry Trends

2.3.2 Next Generation Sequencing Technology Market Drivers

2.3.3 Next Generation Sequencing Technology Market Challenges

2.3.4 Next Generation Sequencing Technology Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Next Generation Sequencing Technology Players by Revenue

3.1.1 Global Top Next Generation Sequencing Technology Players by Revenue (2019-2024)

3.1.2 Global Next Generation Sequencing Technology Revenue Market Share by Players (2019-2024)

3.2 Global Next Generation Sequencing Technology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Next Generation Sequencing Technology Revenue

3.4 Global Next Generation Sequencing Technology Market Concentration Ratio

3.4.1 Global Next Generation Sequencing Technology Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Next Generation Sequencing Technology Revenue in 2023

3.5 Next Generation Sequencing Technology Key Players Head office and Area Served

3.6 Key Players Next Generation Sequencing Technology Product Solution and Service

3.7 Date of Enter into Next Generation Sequencing Technology Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Next Generation Sequencing Technology Breakdown Data by Type

4.1 Global Next Generation Sequencing Technology Historic Market Size by Type (2019-2024)

4.2 Global Next Generation Sequencing Technology Forecasted Market Size by Type (2025-2030)

5 Next Generation Sequencing Technology Breakdown Data by Application

5.1 Global Next Generation Sequencing Technology Historic Market Size by Application (2019-2024)

5.2 Global Next Generation Sequencing Technology Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Next Generation Sequencing Technology Market Size (2019-2030)

6.2 North America Next Generation Sequencing Technology Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Next Generation Sequencing Technology Market Size by Country (2019-2024)

6.4 North America Next Generation Sequencing Technology Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Next Generation Sequencing Technology Market Size (2019-2030)

7.2 Europe Next Generation Sequencing Technology Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Next Generation Sequencing Technology Market Size by Country (2019-2024)

7.4 Europe Next Generation Sequencing Technology Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Next Generation Sequencing Technology Market Size (2019-2030)

8.2 Asia-Pacific Next Generation Sequencing Technology Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Next Generation Sequencing Technology Market Size by Region (2019-2024)

8.4 Asia-Pacific Next Generation Sequencing Technology Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Next Generation Sequencing Technology Market Size (2019-2030)

9.2 Latin America Next Generation Sequencing Technology Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Next Generation Sequencing Technology Market Size by Country (2019-2024)

9.4 Latin America Next Generation Sequencing Technology Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Next Generation Sequencing Technology Market Size (2019-2030)

10.2 Middle East & Africa Next Generation Sequencing Technology Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Next Generation Sequencing Technology Market Size by Country (2019-2024)

10.4 Middle East & Africa Next Generation Sequencing Technology Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Eurofins Scientific

11.1.1 Eurofins Scientific Company Detail

11.1.2 Eurofins Scientific Business Overview

11.1.3 Eurofins Scientific Next Generation Sequencing Technology Introduction

11.1.4 Eurofins Scientific Revenue in Next Generation Sequencing Technology Business (2019-2024)

11.1.5 Eurofins Scientific Recent Development

11.2 Natera

11.2.1 Natera Company Detail

11.2.2 Natera Business Overview

11.2.3 Natera Next Generation Sequencing Technology Introduction

11.2.4 Natera Revenue in Next Generation Sequencing Technology Business (2019-2024)

11.2.5 Natera Recent Development

11.3 BGI

11.3.1 BGI Company Detail

11.3.2 BGI Business Overview

11.3.3 BGI Next Generation Sequencing Technology Introduction

11.3.4 BGI Revenue in Next Generation Sequencing Technology Business (2019-2024)

11.3.5 BGI Recent Development

11.4 Illumina

11.4.1 Illumina Company Detail

11.4.2 Illumina Business Overview

11.4.3 Illumina Next Generation Sequencing Technology Introduction

11.4.4 Illumina Revenue in Next Generation Sequencing Technology Business (2019-2024)

11.4.5 Illumina Recent Development

11.5 Roche

11.5.1 Roche Company Detail

11.5.2 Roche Business Overview

11.5.3 Roche Next Generation Sequencing Technology Introduction

11.5.4 Roche Revenue in Next Generation Sequencing Technology Business (2019-2024)

11.5.5 Roche Recent Development

11.6 LabCorp

11.6.1 LabCorp Company Detail

11.6.2 LabCorp Business Overview

11.6.3 LabCorp Next Generation Sequencing Technology Introduction

11.6.4 LabCorp Revenue in Next Generation Sequencing Technology Business (2019-2024)

11.6.5 LabCorp Recent Development

11.7 Berry Genomics

11.7.1 Berry Genomics Company Detail

11.7.2 Berry Genomics Business Overview

11.7.3 Berry Genomics Next Generation Sequencing Technology Introduction

11.7.4 Berry Genomics Revenue in Next Generation Sequencing Technology Business (2019-2024)

11.7.5 Berry Genomics Recent Development

11.8 Brooks Life Sciences

11.8.1 Brooks Life Sciences Company Detail

11.8.2 Brooks Life Sciences Business Overview

11.8.3 Brooks Life Sciences Next Generation Sequencing Technology Introduction

11.8.4 Brooks Life Sciences Revenue in Next Generation Sequencing Technology Business (2019-2024)

11.8.5 Brooks Life Sciences Recent Development

11.9 Macrogen

11.9.1 Macrogen Company Detail

11.9.2 Macrogen Business Overview

11.9.3 Macrogen Next Generation Sequencing Technology Introduction

11.9.4 Macrogen Revenue in Next Generation Sequencing Technology Business (2019-2024)

11.9.5 Macrogen Recent Development

11.10 Personalis

11.10.1 Personalis Company Detail

11.10.2 Personalis Business Overview

11.10.3 Personalis Next Generation Sequencing Technology Introduction

11.10.4 Personalis Revenue in Next Generation Sequencing Technology Business (2019-2024)

11.10.5 Personalis Recent Development

11.11 Novogene

11.11.1 Novogene Company Detail

11.11.2 Novogene Business Overview

11.11.3 Novogene Next Generation Sequencing Technology Introduction

11.11.4 Novogene Revenue in Next Generation Sequencing Technology Business (2019-2024)

11.11.5 Novogene Recent Development

11.12 Genotypic Technology

11.12.1 Genotypic Technology Company Detail

11.12.2 Genotypic Technology Business Overview

11.12.3 Genotypic Technology Next Generation Sequencing Technology Introduction

11.12.4 Genotypic Technology Revenue in Next Generation Sequencing Technology Business (2019-2024)

11.12.5 Genotypic Technology Recent Development

11.13 Dna Link

11.13.1 Dna Link Company Detail

11.13.2 Dna Link Business Overview

11.13.3 Dna Link Next Generation Sequencing Technology Introduction

11.13.4 Dna Link Revenue in Next Generation Sequencing Technology Business (2019-2024)

11.13.5 Dna Link Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

Companies Mentioned:

Eurofins Scientific

Natera

BGI

Illumina

Roche

LabCorp

Berry Genomics

Brooks Life Sciences

Macrogen

Personalis

Novogene

Genotypic Technology

Dna Link

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂